Keywords: GlaxoSmithKline, H5N1 flu vaccine, USA, FDA advisory panel, Pumarix

FDA advisory panel backs GlaxoSmithKline H5N1 influenza vaccine candidate

Article | 15 November 2012

Print This

The US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously 14-0 that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in